Steve Miller - Chief Op. & Scientific Officer at CATALYST PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Op. & Scientific Officer
Issuer Symbol
CPRX on Nasdaq
All Insider Reports
All Insider Reports

Steve Miller - trading volume in the past year for CATALYST PHARMACEUTICALS, INC.

Holdings reported by Steve Miller for CATALYST PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock, par value $0.001 per share 1,093,803 $25,802,812 $23.59 29 Dec 2025 Direct
Restricted Stock Units 1,471,649 $3,414,900 $2.24 29 Dec 2025 Direct Common Stock
Options to purchase common stock 1,457,963 20 Nov 2025 Direct Common Stock

Transactions reported by Steve Miller for CATALYST PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.